Skip to content
Biodatica
Start free

Investigator

Misha Yuri Zilberter

J. DAVID GLADSTONE INSTITUTES · funded by NIA

Companies
3

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$2.4M

Summed across those awards.

First award
Dec 15, 2024

Latest Jun 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Targeting Nell2 and GABAergic Dysfunction to Mitigate APOE4-Driven Pathogenesis in Alzheimer's Disease

    $804k

    Jun 1, 2025NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11100623 (opens the source filing in a new tab)

  2. R01

    Targeting Nell2 and GABAergic Dysfunction to Mitigate APOE4-Driven Pathogenesis in Alzheimer's Disease

    $779k

    Jun 1, 2025NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11332530 (opens the source filing in a new tab)

  3. R01

    Exploring NOX2-Mediated Network Impairment and Neurodegeneration in Alzheimer's Disease

    $842k

    Dec 15, 2024NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11241118 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources